Hawk Ernest T, Greenwood Addison, Gritz Ellen R, McTiernan Anne, Sellers Thomas, Hursting Stephen D, Leischow Scott, Grad Oren
National Cancer Institute, Bethesda, Maryland, USA.
Clin Cancer Res. 2008 Sep 15;14(18):5707-13. doi: 10.1158/1078-0432.CCR-08-1262.
The Translational Research Working Group (TRWG) was created as a national initiative to evaluate the current status of National Cancer Institute's investment in translational research and envision its future. The TRWG conceptualized translational research as a set of six developmental processes or pathways focused on various clinical goals. One of those pathways describes the development of lifestyle alterations, which can, variously, be recommended to prevent cancer, modify a patient's adherence and response to cancer treatment, ameliorate side effects of cancer treatments, or improve prognosis and quality of life in cancer patients and survivors. The lifestyle alteration pathway was conceived not as a comprehensive description of the corresponding real-world processes, but rather as a tool designed to facilitate movement of a candidate lifestyle alteration through the translational process up to the point where it could be handed off for definitive testing, when appropriate. This article discusses key issues associated with the development of lifestyle alterations in light of the pathway.
转化研究工作组(TRWG)作为一项全国性倡议而成立,旨在评估美国国立癌症研究所(National Cancer Institute)在转化研究方面的投资现状并展望其未来。TRWG将转化研究概念化为一组围绕各种临床目标的六个发展过程或途径。其中一条途径描述了生活方式改变的发展,这些改变可以不同方式被推荐用于预防癌症、改变患者对癌症治疗的依从性和反应、改善癌症治疗的副作用,或改善癌症患者及幸存者的预后和生活质量。生活方式改变途径并非旨在全面描述相应的现实世界过程,而是作为一种工具,旨在促进候选生活方式改变在转化过程中的推进,直至在适当时可以将其交付进行确定性测试。本文根据该途径讨论与生活方式改变发展相关的关键问题。